These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25767263)

  • 1. Invited commentary: driving for further evolution.
    Hiatt RA
    Am J Epidemiol; 2015 Apr; 181(7):459-62. PubMed ID: 25767263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.
    Lam TK; Chang CQ; Rogers SD; Khoury MJ; Schully SD
    Am J Epidemiol; 2015 Apr; 181(7):451-8. PubMed ID: 25767265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lam et al. respond to "Driving for further evolution".
    Lam TK; Chang CQ; Rogers SD; Khoury MJ; Schully SD
    Am J Epidemiol; 2015 Apr; 181(7):463. PubMed ID: 25767264
    [No Abstract]   [Full Text] [Related]  

  • 4. Training the Twenty-First Century Cancer Epidemiologist.
    Lam TK; Lavigne JA; Qadir X; Khoury MJ; Schully SD
    J Cancer Educ; 2019 Dec; 34(6):1181-1189. PubMed ID: 30251077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for translational epidemiology: the important role of observational studies to advance precision oncology.
    Marrone M; Schilsky RL; Liu G; Khoury MJ; Freedman AN
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):484-9. PubMed ID: 25750251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited commentary: The epicenter of translational science.
    Hiatt RA
    Am J Epidemiol; 2010 Sep; 172(5):525-7; discussion 528-9. PubMed ID: 20688901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.
    Lam TK; Spitz M; Schully SD; Khoury MJ
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):181-8. PubMed ID: 23322363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
    Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
    Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming epidemiology for 21st century medicine and public health.
    Khoury MJ; Lam TK; Ioannidis JP; Hartge P; Spitz MR; Buring JE; Chanock SJ; Croyle RT; Goddard KA; Ginsburg GS; Herceg Z; Hiatt RA; Hoover RN; Hunter DJ; Kramer BS; Lauer MS; Meyerhardt JA; Olopade OI; Palmer JR; Sellers TA; Seminara D; Ransohoff DF; Rebbeck TR; Tourassi G; Winn DM; Zauber A; Schully SD
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):508-16. PubMed ID: 23462917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doug Lowy becomes acting director of National Cancer Institute.
    Schmidt C
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957443
    [No Abstract]   [Full Text] [Related]  

  • 11. Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death".
    Roberts SF; Fischhoff MA; Sakowski SA; Feldman EL
    Acad Med; 2012 Mar; 87(3):266-70. PubMed ID: 22373616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaborative cancer epidemiology in the 21st century: the model of cancer consortia.
    Burgio MR; Ioannidis JP; Kaminski BM; Derycke E; Rogers S; Khoury MJ; Seminara D
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2148-60. PubMed ID: 24045926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational Research: The Cornerstone for Medical Technology Advancement.
    Tellez A; Ferrone M; Granada JF
    Toxicol Pathol; 2019 Apr; 47(3):203-204. PubMed ID: 30744501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. StatBite: Stimulus funding: where does the NCI propose to invest?
    J Natl Cancer Inst; 2009 Sep; 101(17):1169. PubMed ID: 19679852
    [No Abstract]   [Full Text] [Related]  

  • 15. Interview with director John E. Niederhuber, M.D.: National Cancer Institute stakes out new directions with stimulus funds.
    Niederhuber JE
    J Natl Cancer Inst; 2009 Sep; 101(17):1169. PubMed ID: 19736666
    [No Abstract]   [Full Text] [Related]  

  • 16. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCI Funding Trends and Priorities in Physical Activity and Energy Balance Research Among Cancer Survivors.
    Alfano CM; Bluethmann SM; Tesauro G; Perna F; Agurs-Collins T; Elena JW; Ross SA; O'Connell M; Bowles HR; Greenberg D; Nebeling L
    J Natl Cancer Inst; 2016 Jan; 108(1):. PubMed ID: 26547926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next steps in clinical trial redesign.
    Nicholas J
    J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851
    [No Abstract]   [Full Text] [Related]  

  • 19. Evolution in translational science: Whither the CTSAs?
    FitzGerald GA
    Sci Transl Med; 2015 Apr; 7(284):284fs15. PubMed ID: 25904737
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.